www.flaretx.com/HealthcareFounded: 2021Funding to Date: $207MM
Flare Therapeutics is a biotechnology company seeking to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address mutations that cause disease.
View Enterprise Value for Flare Therapeutics.